基于CAR的固体瘤免疫疗法的最新进展
Min Hwa Shin1, Eunha Oh1, Yunjeong Kim1
1Immune Research Institute, Seegene Medical Foundation, Seoul 04805, Republic of Korea.
Cells
|June 28, 2023
概括
化学抗原受体 (CAR) 工程化免疫细胞,包括CAR-T,CAR-NK和CAR-M,显示出对固体瘤免疫疗法的希望. 研究人员正在探索先进的CAR设计和替代性免疫细胞,以克服瘤微环境和抗原特异性等挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 化学抗原受体 (CAR) T细胞疗法对血液癌症有效,但在固体瘤中面临挑战,包括免疫抑制瘤微环境 (TME),透不良以及缺乏特定抗原.
- 最近的CAR-T进步,如共刺激域和装甲CAR-T细胞,显示出潜力,但需要进一步开发.
- 自然杀手 (NK) 细胞和巨细胞 (M) 由于其独特的特性,正在成为用于固体瘤免疫治疗的CAR工程替代平台.
研究的目的:
- 审查工程免疫细胞基础的癌症免疫疗法对固体瘤的最新进展.
- 讨论CAR-T,CAR-NK和CAR-M疗法的挑战和未来前景.
- 总结正在进行的临床试验,评估这些工程免疫细胞的安全性和有效性.
主要方法:
- 关于CAR-T,CAR-NK和CAR-M细胞疗法的最新科学文献的综述.
- 分析CAR电池设计和工程策略的进展.
- 来自正在进行的临床试验的数据汇编,用于针对固体瘤的工程免疫细胞.
主要成果:
- 卡尔-T细胞在血液性恶性瘤中表现出有效性,但与固体瘤作斗争.
- 卡尔-NK细胞提供"现成"的可用性和低毒性,显示临床改善.
- 由于巨细胞能够透到固体瘤的TME,CAR-M细胞具有潜力.
结论:
- 工程免疫细胞,特别是CAR-NK和CAR-M,为固体瘤提供了有前途的治疗途径.
- 克服与TME相关的挑战和识别瘤特异性抗原对于提高疗效至关重要.
- 目前正在进行的临床试验对于验证这些先进免疫疗法的安全性和有效性至关重要.
相关概念视频
01:27Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
01:30Cancer Vaccines
433
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
433
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
02:49Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K